News | Biopsy Systems | August 25, 2016

Soft tissue biopsy system will help radiologists and surgeons characterize tissue abnormalities in real time

August 25, 2016 — Dune Medical Devices has been selected as one of the few recipients of a European Union Horizon 2020 research grant to spur development of its biopsy system. The 80 billion euro, seven-year program is aimed at securing Europe’s global competitiveness.

Out of more than 1,167 applications in the small and medium (SME) instrument category, Dune Medical Devices is one of only 65 companies that will receive funding through the program.

“This three million euro grant will expedite bringing our soft tissue biopsy system to the market,” says Dan Hashimshony, CEO and Founder of Dune Medical. “It will provide radiologists and surgeons immediate graphic characterizations of tissue abnormalities along the tip of the biopsy needle, just before samples are taken. This real-time insight can help reduce the time to a definite diagnosis and repeated biopsies. Our proprietary biopsy device can also be used in combination with other existing devices.”

The first commercial product based on Dune Medical’s proprietary radio frequency (RF) spectroscopy technology was the MarginProbe. It has been helping surgeons ensure clean margins in lumpectomy procedures since 2013. Based on that success, the company is expanding on its RF spectroscopy platform to develop the next-generation product that will help surgeons perform biopsies.

The new product will expand Dune’s surgical oncology portfolio to include a soft tissue biopsy system with its first indication in breast tissue.

For more information: www.marginprobe.com


Related Content

News | Breast Imaging

June 25, 2025 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time June 25, 2025
arrow
News | Mammography

April 29, 2025 — iCAD, a global provider of clinically proven AI-powered cancer detection solutions, has announced a ...

Time April 29, 2025
arrow
News | Mammography

April 24, 2025 — GE HealthCare will feature its latest advancements in diagnostic accuracy and patient-centered breast ...

Time April 24, 2025
arrow
News | Artificial Intelligence

March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a ...

Time March 10, 2025
arrow
News | Artificial Intelligence

Feb. 19, 2025 — SimonMed Imaging and HeartLung Technologies have signed a strategic partnership to offer HeartLung's AI ...

Time March 04, 2025
arrow
News | Ultrasound Imaging

Jan. 28, 2025 — GE HealthCare recently announced it has received 510(k) clearance from the United States Food and Drug ...

Time January 29, 2025
arrow
News | Breast Imaging

Jan. 8, 2025 — ScreenPoint Medical has acquiredf Biomediq A/S, a research-based company focused on the research ...

Time January 10, 2025
arrow
News | Breast Imaging

Dec.11, 2024 — iCAD, Inc., a provider of clinically proven AI-powered cancer detection solutions, recently announced ...

Time December 18, 2024
arrow
News | Mammography

Dec. 5, 2024 — At RSNA 2024, Lunit and Volpara Health announced their unified vision, focusing on a comprehensive ...

Time December 05, 2024
arrow
News | Mammography

Nov. 26, 2024 — GE HealthCare has introduced the Pristina Via* mammography system designed to enhance the screening ...

Time December 02, 2024
arrow
Subscribe Now